Search

everythinglearnresearchcommunity

for

Search:↓

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

Docetaxel chemotherapy causes more long-term hair loss and dissatisfaction than paclitaxel.

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

Chrysin makes docetaxel more effective and reduces its side effects in lung cancer treatment.

Some chemotherapy can cause permanent hair loss.

Vijaya successfully fought stage 2A breast cancer with surgery, chemotherapy, radiotherapy, and hormone therapy, while advocating for support groups.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

Docetaxel is safe and works well for older people with cancer, with manageable side effects.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Chemotherapy with docetaxel can cause painful nail and skin side effects that may lead to stopping treatment.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Some breast cancer chemotherapy can cause permanent hair loss.

PLD is an effective and safer alternative for treating breast cancer.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

The treatment improved survival and controlled cancer spread but required managing side effects like rashes.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Some breast cancer treatments caused long-term hair loss in women, similar to a condition called alopecia areata.

Penguin Cold Caps help most patients keep at least half their hair during chemotherapy.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Cancer treatments often cause hair loss and damage, affecting patients' mental health.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

CDK4/6 inhibitors can protect hair cells from chemotherapy damage.

Reporter characteristics affect detection of hair loss from cancer therapy.

Chemotherapy for breast cancer often causes significant and lasting hair loss.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.